ASTRAZENECA AS

Fiona Cookson

Head of US Media Relations

Mark T. Esser

Vice President and Head of Microbial Sciences, BioPharmaceuticals R&D

Ruth March

Senior Vice-President of Precision Medicine, R&D Oncology

Adam Platt

VP and Head of Translational Science and Experimental Medicine, Respiratory and Immunology

Nazneen Rahman

Non-Executive Director

Sofia Tapani

Head of Early Respiratory & Immunology Statistics, Executive Director Statistics

Ruud Dobber

Executive Vice-President, BioPharmaceuticals Business Unit

Suzanne Cohen

Executive Director and Head of Bioscience Asthma and Skin Immunity, Respiratory and Immunology (R&I)

Aradhana Sarin

Executive Director and Chief Financial Officer

Pam Cheng

Executive Vice President, Global Operations, IT & Chief Sustainability Officer

Marcus Wallenberg

Non-Executive Director

Mina Makar

Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit

Victoria Parker

Executive Group Director, Metabolism, Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Iskra Reic

Executive Vice-President, International

Rene Haas

Non-Executive Director

Philip Broadley

Senior independent Non-Executive Director

Diana Layfield

Non-Executive Director

Susan Galbraith

Executive Vice-President, Oncology R&D

David Fredrickson

Executive Vice-President, Oncology Business Unit

Sonny Shergill

Vice President, Commercial Digital Health

Tom Keith-Roach

President, AstraZeneca UK

Karen Knudsen

Non-Executive Director

Nayyar Iqbal

Vice President Clinical Metabolism, BioPharmaceuticals R&D

Clive Green

Executive Director and Head of Global Sample Management, Discovery Sciences, R&D

Ryan Hicks

Head of Bioscience Cell Therapy, BioPharmaceuticals R&D

Shawn Davis

Head of Drug Delivery, BioPharmaceuticals Development, R&D

Annette Bak

Head of Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Birgit Conix

Non-Executive Director

Sheri McCoy

Non-Executive Director

Ken Grime

Executive Director and Head of Bioscience COPD & IPF, Respiratory & Immunology (R&I)

Mikhail Kosiborod

Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Malin Lemurell

Executive Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Senior Vice President, Biologics Engineering & Oncology Targeted Delivery

Senior Vice President, Biologics Engineering & Oncology Targeted Delivery

Tonya Villafana

Vice President, Global Franchise Head, Infection

Slavé Petrovski

VP, Centre for Genomics Research, BioPharmaceuticals R&D

Sharon Barr

Executive Vice-President, BioPharmaceuticals R&D

Jeff Pott

Chief Human Resources Officer, Chief Compliance Officer and General Counsel

Martin Cowie

Vice President Clinical Cardiovascular and Renal Clinical Development, BioPharmaceuticals R&D

Pascal Soriot

Executive Director and Chief Executive Officer

Steve Rees

SVP, Discovery Sciences, R&D

Marc Dunoyer

Chief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca

Andy Barnett

Head of Investor Relations

Cassie Gregson

Vice President, R&D IT

Lutz Jermutus

Head of Projects

Euan Ashley

Non-Executive Director

Regina Fritsche-Danielson

Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Shalini Andersson

Vice President Oligonucleotide Discovery, Discovery Sciences

Tony Mok

Non-Executive Director

Kenny Hansson

Executive Director and Head of Bioscience Cardiovascular, Cardiovascular, Renal and Metabolism (CVRM)

Anna Manz

Non-Executive Director

Cristina Durán

Chief Digital Health Officer, R&D

Michel Demaré

Non-Executive Chair of the Board

Rasmus Jansson-Löfmark

Executive Director and Head of DMPK, Early CVRM

Lauren-Jei McCarthy

Director, US Media Relations

Freja Annamatz

Director, Media Relations, Sweden

Ricardo Blanco

Director, Media Relations, Latin America

Isabel Gibson

Director of Investor Relations (Oncology)

Elizabeth Walton

Director of Investor Relations (BioPharmaceuticals (Respiratory & Immunology))

Tina Rydén-Bergsten

Global Product Leader, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Nicolas Jose Guzman

Director Physician, Nephrology Clinical Research

Andrew Christmas

Director of Investor Relations (Rare Disease and Sustainability)

Lishan Soon

Senior Director, International Communication

Christer Gruvris

Executive Director of Investor Relations (BioPharmaceuticals (Cardiovascular, Renal and Metabolism), Finance & Fixed Income)

Philip Sparks

Director of Investor Relations (BioPharmaceuticals (Vaccines & Immune Therapies) and Sustainability)

Ola Engkvist

Associate Director, Computational Chemistry, Discovery Sciences, R&D

Lauren Swales

Director of Investor Relations (Rare Disease)

Louise Pearson

Director of Investor Relations (Oncology)

Simon Bradford

Data & Analytics Enabling Units Engineering Lead

Tatiana Scetinina

Director, Data Science

Fredrik Röök

Transaction Director, Business Development Operations

Magnus Johansson

Principal Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Marianne Ashford

Senior Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Alan Sabirsh

Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Qing-Dong Wang

Senior Principal Scientist, Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D